Tofacitinib Tablets IP

Key Benefits
- Helps reduce inflammation associated with autoimmune conditions
- Supports the management of rheumatoid arthritis
- Used in appropriate patients with psoriatic arthritis
- Helps manage moderate-to-severe ulcerative colitis
- May improve symptoms such as joint pain, swelling, and stiffness
- Provides targeted inhibition of JAK-mediated inflammatory signaling
How It Works
Tofacitinib inhibits Janus kinase (JAK) enzymes, which are involved in signaling pathways used by various inflammatory cytokines. By reducing these signals, it helps decrease excessive immune-system activity and inflammation involved in certain autoimmune diseases.
Common Side Effects
- Headache
- Upper respiratory tract infections
- Nasopharyngitis
- Diarrhea
- Nausea
- Increased cholesterol levels
- Increased risk of infections
Important Information
Tofacitinib Tablets IP should be used under the supervision of a qualified healthcare professional. It can increase the risk of serious infections, including tuberculosis and other opportunistic infections. Regular monitoring may be required, including blood counts, liver function, and lipid levels. Tofacitinib may also increase the risk of blood clots, cardiovascular events, and certain cancers in some patients. Inform your doctor about any history of infections, blood clots, heart disease, liver or kidney problems, and all medicines you are taking. Seek immediate medical attention for severe infection symptoms, chest pain, sudden breathing difficulty, or swelling or pain in an arm or leg.